Immune Response Not Inferior With Coadministration of COVID-19, Flu Shots
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Sept. 14, 2023 -- The immune response and occurrence of adverse events were similar for health care workers receiving coadministration of COVID-19 and influenza vaccines or COVID-19 vaccine alone, according to a study published online Sept. 8 in JAMA Network Open.
Tal Gonen, M.D., from Sheba Medical Center in Tel Hashomer, Israel, and colleagues compared the reactogenicity and immunogenicity of COVID-19 and influenza vaccinations administered together to those of COVID-19 vaccination alone in a prospective cohort study involving participants who received the Influvac Tetra (Abbott) influenza vaccine (2022/2023), the omicron BA.4/BA.5-adapted bivalent (Pfizer/BioNTech) vaccine, or both. Two cohorts were included for two analyses: The reactogenicity analysis included 588 participants (85 in the COVID-19 vaccine-alone group; 357 in the influenza vaccine-alone group; and 146 in the coadministration group), and the immunogenicity analysis included 151 participants (74 in the COVID-19 vaccine group and 77 in the coadministration group).
The researchers found that the risk for systemic symptoms was similar in the coadministration group compared with the COVID-19 vaccination-alone group (odds ratio, 0.82; 95 percent confidence interval, 0.43 to 1.56). In the coadministration group, geometric mean titers were estimated to be 0.84 (95 percent confidence interval, 0.69 to 1.04) times lower than in the COVID-19 vaccine-alone group.
"We believe that our results suggest that the coadministration of this COVID-19 vaccine along with seasonal influenza vaccination is a feasible and harmless tactic to increase vaccine uptake," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Further Support and Information on COVID-19
Read this next
Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up
WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study...
Long-Term Smell, but Not Taste, Deficits Seen After COVID-19
WEDNESDAY, May 1, 2024 -- Olfactory dysfunction, especially for smell, is more common in individuals with prior COVID-19 versus individuals with no history of infection, with...
SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk
TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.